Letrozole: An Advanced Aromatase Inhibitor for Breast Cancer Therapy
Discover the efficacy and quality of Letrozole (CAS 112809-51-5), a key pharmaceutical ingredient in advanced breast cancer treatment, offered by a trusted supplier in China.
Get a Quote & SampleProduct Core Value
Letrozole
We are a leading manufacturer and supplier of high-quality Letrozole (CAS 112809-51-5) in China. Our product meets stringent quality standards, boasting a purity of 99%min, adhering to USP, BP, EP, and FCC standards. Letrozole is a critical pyrrole-type aromatase inhibitor used in the treatment of breast cancer, particularly effective for post-menopausal women. Its mechanism involves significantly reducing estrogen levels, thereby slowing or halting the growth of hormone-sensitive breast cancer cells. We provide competitive pricing and online purchase support, ensuring a reliable supply chain for pharmaceutical needs.
- Discover the advanced application of hormone therapy for breast cancer treatment with our high purity Letrozole.
- As a trusted pharmaceutical API supplier, we ensure consistent quality and availability for your critical research and production needs.
- Learn more about the buy Letrozole online options and secure your supply from a reliable source.
- Our commitment to quality makes us a leading manufacturer of Letrozole for demanding therapeutic applications.
Advantages of Choosing Our Letrozole
Exceptional Purity
Our Letrozole (CAS 112809-51-5) is guaranteed to be at least 99% pure, ensuring efficacy and reliability for pharmaceutical applications. This high standard is crucial for effective hormone therapy for breast cancer treatment.
Strict Quality Adherence
We comply with USP, BP, EP, and FCC standards, providing confidence in the quality and safety of our product for critical medical use. Sourcing high purity Letrozole is paramount.
Competitive Pricing & Support
Benefit from competitive pricing and dedicated online purchase support, making it easier for you to buy Letrozole and maintain your supply chain. Secure your pharmaceutical API needs with us.
Key Applications
Breast Cancer Treatment
Letrozole is a cornerstone in treating hormone receptor-positive breast cancer, especially in post-menopausal women, by significantly lowering estrogen levels. This is vital for hormone therapy for breast cancer treatment.
Aromatase Inhibition
As a powerful aromatase inhibitor, Letrozole effectively blocks the enzyme responsible for estrogen production, a critical mechanism in managing hormone-dependent cancers.
Reducing Recurrence Risk
Its application extends to reducing the risk of breast cancer recurrence, making it a vital component in adjuvant therapy protocols for many patients.
Advanced Cancer Management
Letrozole plays a crucial role in managing advanced-stage breast cancer, helping to slow or stop disease progression and improve patient outcomes, supporting effective cancer treatment strategies.